V. Gamble

发表

Neonatal presentation of autosomal dominant polycystic kidney disease with a maternal history of tuberous sclerosis.

V. Torres, P. Harris, D. Milliner, 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Screening the 3' region of the polycystic kidney disease 1 (PKD1) gene reveals six novel mutations.

P. Harris, C. Ward, J. L. San Millán, 1996, American journal of human genetics.

Gene (PKD1) by a Novel Approach

K. Zerres, P. Harris, C. Winearls, 2006 .

Discovery of a Chemical Tool Inhibitor Targeting the Bromodomains of TRIM24 and BRPF

S. Knapp, O. Fedorov, S. Müller, 2015, Journal of medicinal chemistry.

Discovery of an MLLT1/3 YEATS Domain Chemical Probe

Jennifer A. Ward, S. Knapp, G. Poda, 2018, Angewandte Chemie.

Delta12-prostaglandin D2 is a potent and selective CRTH2 receptor agonist and causes activation of human eosinophils and Th2 lymphocytes.

Chris Allan, L. Xue, G. Speight, 2005, Prostaglandins & other lipid mediators.

Discovery of a Selective Inhibitor for the YEATS Domains of ENL/AF9

G. Poda, O. Fedorov, R. Al-awar, 2018, SLAS discovery : advancing life sciences R & D.

Assessing histone demethylase inhibitors in cells: lessons learned

G. F. Ruda, O. Fedorov, C. Bountra, 2017, Epigenetics & Chromatin.

THE POLYCYSTIC KIDNEY-DISEASE-1 GENE ENCODES A 14-KB TRANSCRIPT AND LIES WITHIN A DUPLICATED REGION ON CHROMOSOME-16

Siep Thomas, S. Verhoef, J. Hughes, 1994 .

Recurrence of the PKD1 nonsense mutation Q4041X in Spanish, Italian, and British families

X. Estivill, E. Serra, P. Harris, 1998, Human mutation.

Discovery of High-Affinity Small-Molecule Binders of the Epigenetic Reader YEATS4.

K. Fennell, O. Fedorov, P. Loria, 2022, Journal of medicinal chemistry.

Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease — a contiguous gene syndrome

J. Hughes, P. Harris, C. Ward, 1994, Nature Genetics.

Mutation analysis of the entire PKD1 gene: genetic and diagnostic implications.

A. Bakkaloğlu, L. Strmečki, P. Harris, 2001, American journal of human genetics.

The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains

J. Hughes, P. Harris, C. Ward, 1995, Nature Genetics.

Splicing mutations of the polycystic kidney disease 1 (PKD1) gene induced by intronic deletion.

J. Sloane-Stanley, F. Moreno, P. Harris, 1995, Human molecular genetics.

BET inhibition as a new strategy for the treatment of gastric cancer

S. Knapp, O. Fedorov, S. Müller, 2016, Oncotarget.

Biological Evaluation of Benzothiazole Ethyl Urea Inhibitors of Bacterial Type II Topoisomerases

L. Czaplewski, C. Smee, I. Collins, 2013, Antimicrobial Agents and Chemotherapy.

A stable, nonsense mutation associated with a case of infantile onset polycystic kidney disease 1 (PKD1).

P. Harris, J. L. San Millán, A. Ong, 1996, Human molecular genetics.

Identification of mutations in the duplicated region of the polycystic kidney disease 1 gene (PKD1) by a novel approach.

K. Zerres, J. Sloane-Stanley, P. Harris, 1997, American journal of human genetics.

Assessing histone demethylase inhibitors in cells: lessons learned

G. F. Ruda, O. Fedorov, C. Bountra, 2017, Epigenetics & Chromatin.